Therapeutic Hypothermia After Cardiac Arrest

John McPherson

Updates in Transcatheter Tricuspid Regurgitation Therapies: Where Ar…

Nicholas Amoroso

TCT 2024 Insights: Insights from the DanGer Shock and ECLS-Shock Tri…

TCT 2024 Insights

G. Tarantini

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

The Tricuspid Valve: Correlating Anatomy, Imaging, and Intervention

Scripps Health

D. Shook

An Endoscopic Journey Through the Human Heart

Controversies in Interventional Cardiovascular Therapies - CICT 2024

S. Mori

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Esmolol in Refractory VF

The 9th Annual Western New England Acute Cardiology Conference

B. Hoffman

How Do We Interpret Tricuspid TEER Trials and Registries?

New York Transcatheter Valves 2023

P. Sorajja

Prosthetic Valve Choice in Heart Valve Surgery

Mitral Foundation

A. Anyanwu

Timing and Choice of Percutaneous Mechanical Circulatory Support (pM…

UChicago Medicine

S. Nathan

Heterotopic Tricuspid Replacement: CAVI

University of Miami

F. De Brito Jr.

Investigational Options for Tricuspid Regurgitation

Penn Medicine Heart and Vascular Center

P. Fiorilli